Journal home
Advance online publication
Current issue
Archive
Press releases
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews Immunology
Nature Medicine
Nature Cell Biology
NI Tutorial: Finding regulatory DNA regions
Signaling Gateway
Immunology & Cell Biology
Mucosal Immunology
Nature Conferences
Nature Stem Cells
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Immunology  3, 564 - 569 (2002)
Published online: 20 May 2002; | doi:10.1038/ni800

Early TCRalpha expression generates TCRalphabig gamma complexes that signal the DN-to-DP transition and impair development

Batu Erman1, Lionel Feigenbaum2, John E. Coligan3 & Alfred Singer1

1 Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

2 SAIC Frederick, NCI-Frederick Cancer Research and Development Center, Frederick, MD 21702, USA.

3 Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.

Correspondence should be addressed to Alfred Singer Singera@nih.gov
Clonotypic T cell receptor (TCR) genes undergo ordered rearrangement and expression in the thymus with the result that TCRalpha and TCRbold gamma proteins are not expressed in the same cell at the same time. Such "TCRalpha/bold gamma exclusion" is a feature of normal thymocyte differentiation, but it is abrogated in TCR-transgenic mice, which prematurely express transgenic TCRalpha proteins in early double-negative (DN) thymocytes. We report here that early expression of TCRalpha proteins results in the formation of TCRalphabold gamma complexes that efficiently signal the differentiation of DN into double-positive thymocytes independently of pre-TCR and TCRbeta expression. Thus, abrogation of TCRalpha/bold gamma exclusion by early TCRalpha expression results in the formation of isotypically mixed TCRalphabold gamma complexes whose in vivo signals circumvent TCRbeta selection and redirect thymocyte development along an aberrant developmental pathway.
T cell receptor alpha (TCRalpha) proteins are unique among clonotypic TCR chains because they are excluded from early double-negative (DN) CD4-CD8-thymocytes. The genes encoding TCRbeta, TCRgamma and TCRdelta all rearrange in thymocytes at the DN stage of development, so an individual DN thymocyte might contain one or more of these clonotypic protein chains1, 2, 3, 4. In contrast, TCRalpha gene rearrangement is delayed until thymocytes have been signaled to differentiate into CD4+CD8+ double positive (DP) cells, at which stage TCRgamma expression is transcriptionally silenced5, 6, 7. As a result, TCRalpha and TCRgamma proteins are not normally present in the same cell at the same time. Whether such "TCRalpha/gamma exclusion" is of developmental significance is not known, but it is abrogated in TCR-transgenic mice, which prematurely express TCRalpha-transgenic proteins in DN thymocytes that might also contain TCRgamma proteins.

At the DN stage of differentiation, developing thymocytes commit to either the alphabeta or gammadelta T cell lineages. The nature of the intrathymic signals that dictate the alphabeta-gammadelta lineage choice remains uncertain, but signaling by TCRgammadelta complexes is associated with commitment to the gammadelta T cell lineage, whereas signaling by pTalpha-TCRbeta complexes is associated with commitment to the alphabeta T cell lineage. It is not clear whether the alphabeta-gammadelta lineage choice is dictated by the identity of the TCR signaling complex or whether it is dictated by other factors, such as the timing, intensity or duration of the transduced TCR signals. The concept that the alphabeta-gammadelta lineage decision is dictated by factors other than the identity of the TCR signaling complex is supported by observations that TCR signals at the DN2 stage of development may drive differentiation into gammadelta-lineage T cells, even when the stimulatory signals are transduced by transgenic TCRalphabeta complexes8, 9. Similarly, TCR signals at the DN3 stage of development appear to drive development of alphabeta-lineage T cells that differentiate into CD4+CD8+ DP thymocytes, even when the stimulatory signals are transduced by TCR complexes composed of pre-Talpha (pTalpha) and transgenic TCRgamma chains7. Thus, the timing of TCR signaling in developing thymocytes appears to influence lineage choice and developmental fate.

Here, we specifically considered whether coexpression of TCRalpha and TCRgamma proteins in the same DN thymocyte alters thymocyte development. It seems that coexpression of TCRalpha and TCRgamma proteins in the same DN thymocytes would be unlikely to have much impact, as TCRalpha and TCRgamma proteins are of different TCR isotypes and so might be constrained from assembling into a functional TCRalphagamma complex. However, the rules of TCR assembly, as they are currently understood, do not preclude the formation of mixed isotype TCR complexes. Indeed, isotypically mixed TCRbetadelta complexes have been observed, although only in a human leukemia cell line10. We show here that early expression of TCRalpha in immature DN thymocytes does result in formation of isotypically mixed TCRalphagamma complexes, and that these TCRalphagamma complexes efficiently signal the differentiation of DN into DP thymocytes independently of the pre-TCR, generating DP cells that are TCRbeta- and therefore unable to further differentiate into mature T cells. These results indicate that abrogation of TCRalphagamma exclusion by transgenic TCRalpha expression in DN thymocytes results in the formation of TCRalphagamma complexes whose in vivo signals circumvent TCRbeta selection and redirect thymocyte differentiation along an aberrant developmental pathway.

Results
Paradoxical effect of early TCRalpha expression
To examine the consequences of early TCRalpha expression in DN thymocytes, we constructed a transgene encoding 2B4 TCR Valpha11 cDNA driven by human CD2 promoter and enhancer elements, and used this transgene to generate TCRalpha-transgenic mice11, 12, 13. Assessment of TCRbeta protein expression in thymocytes from TCRalpha transgenic mice revealed profound but unanticipated effects of TCRalpha transgene expression on alphabeta T cell development (Fig. 1a). In normal C57BL/6 (B6) mice, DP thymocytes are the progeny of DN thymocytes that expressed TCRbeta proteins and so could be signaled by pre-TCR complexes to differentiate into DP cells14 (Fig. 1a). As a result, essentially all DP thymocytes are TCRbeta+ by intracellular staining, although a significant minority of DP thymocytes do not express TCRbeta on their cell surfaces because of a failure to productively rearrange and express TCRalpha (Fig. 1a). We anticipated that the introduction of an already rearranged TCRalpha transgene, such as the 2B4 transgene, would promote TCRbeta surface expression on 100% of DP thymocytes; what we observed was almost the exact opposite. Instead of DP thymocytes that were 100% surface TCRbeta+, expression of the 2B4 TCRalpha transgene resulted in DP thymocytes that were almost all TCRbeta-, by both intracellular and extracellular staining (Fig. 1a). The generation of TCRbeta- DP thymocytes was not limited to mice that expressed the 2B4 TCR Valpha11 transgene, as identical results were obtained with mice that expressed a different TCRalpha (TCR Valpha2) transgene, whose expression was also driven by human CD2 control elements (data not shown). This did not result from some complex interaction between transgenic and endogenous TCRalpha proteins, as TCRbeta- DP thymocytes also appeared upon introduction of the TCRalpha transgene into TCRalpha-/- mice that did not express endogenous TCRalpha proteins (Fig 1a).

Figure 1. Expression of TCRalpha transgenes results in the generation of TCRbeta- DP cells.
Figure 1 thumbnail

(a) Detection of TCRbeta- DP thymocytes in TCRalpha-transgenic mice. TCRalpha cDNAs were expressed under the control of a human CD2 promoter-enhancer construct. Thymocytes were stained for CD4 and CD8 surface expression as well as either surface or intracellular TCRbeta (TCRbeta ic). (Left panels) CD4 and CD8 expression are shown as contour plots. Numbers under the contour plots indicate the mean plusminus s.e.m. numbers of thymocytes for each strain (n = three mice for each group); numbers above the contour plots indicate the percentage of DP thymocytes. (Right panels) Surface and intracellular TCRbeta staining of DP thymocytes (solid lines) are compared to that of TCRbeta-/- thymocytes as a negative control (dotted lines). TCRalpha-/- TCRalpha-transgenic profiles were acquired on a different day to the other profiles. (b) Detection of nascent TCRbeta proteins in purified TCRbeta- DP thymocytes from TCRalpha-transgenic mice. Electronically sorted TCRbeta- DP thymocytes from TCRalpha-transgenic mice were metabolically labeled in vitro. NP-40 lysates were then immunoprecipitated with anti-TCRbeta (H57-597), clonotypic anti-TCRalpha (A2B4) or no antibody (Med) and separated on 10% SDS-PAGE under reducing conditions. Unlike normal B6 thymocytes, TCRbeta- DP thymocytes from TCRalpha-transgenic mice did not synthesize TCRbeta proteins (lanes 2, 4), whereas they did synthesize transgenic TCRalpha proteins (lanes 1, 3). Tg, transgenic.



Full FigureFull Figure and legend (73K)
The disappearance of TCRbeta+ DP thymocytes in TCRalpha transgenic mice may result in part from the early expression of TCRalphabeta complexes that arrest thymocyte development at the DN stage of differentiation9, 15, 16. In contrast, the replacement of TCRbeta+ DP thymocytes with TCRbeta- DP thymocytes in TCRalpha-transgenic mice has not previously been appreciated and cannot be explained by any currently known mechanism for DP thymocyte generation. As a result, we wished to verify that DP thymocytes that were TCRbeta- by staining were not synthesizing TCRbeta proteins. To do so, we purified surface TCRbeta- DP thymocytes and metabolically labeled their nascent proteins in vitro (Fig. 1b). In fact TCRbeta- DP thymocytes from TCRalpha-transgenic mice were not synthesizing TCRbeta proteins (Fig 1b, lane 2), even though they were synthesizing transgenic 2B4 TCRalpha proteins (Fig 1b, lane 1).

Early TCRalpha expression induces TCRalphabold gamma complexes
To explain the generation of TCRbeta- DP thymocytes, we speculated that premature expression of TCRalpha proteins in DN thymocytes might have resulted in the formation of an unknown TCRalpha receptor complex that signaled the DN to DP transition before TCRbeta rearrangements, thereby circumventing beta-selection and promoting the generation of TCRbeta- DP thymocytes. If such a TCRalpha complex were formed in DN thymocytes, we thought it most likely to be a TCRalphagamma complex, as all known TCR complexes consist of paired TCR chains, one of which has two positive transmembrane charges (for example TCRalpha, TCRdelta, pTalpha) and the other of which has only one positive transmembrane charge (for example TCRgamma, TCRbeta)7, 10, 17, 18, 19.

To determine whether TCRalpha expression in early DN thymocytes actually resulted in formation of TCRalphagamma complexes that signal the DN to DP transition, we introduced the TCRalpha transgene into recombination-activating gene 2−deficient (referred to hereafter as RAG-/-) and TCRbeta-/-TCRdelta-/- (referred to hereafter as TCRbeta-/-delta-/-) mice. Thymocytes from both RAG-/- and TCRbeta-/-delta-/- mice were arrested at the DN stage of development (Fig. 2a, groups 1, 2). Introduction of the TCRalpha transgene into RAG-/- mice (which potentially express only pTalpha chains) did not result in any DP thymocytes, showing that TCRalpha did not associate with pTalpha chains to signal the DN to DP transition (Fig. 2a, group 1). However, introduction of the TCRalpha transgene into TCRbeta-/-delta-/- mice (which potentially express both pTalpha and TCRgamma chains) resulted in the generation of >12 times 106 DP thymocytes (Fig. 2a, group 2), indicating that TCRalpha and TCRgamma chains do associate to form TCRalphagamma complexes that signal the DN to DP transition. Unlike DP thymocytes from normal B6 mice, which are CD25-negative20, DP thymocytes from TCRalpha-transgenic TCRbeta-/-delta-/- mice were CD25+ (Fig. 2b). This suggested that they were the progeny of CD25+ DN thymocytes that had not extinguished CD25 expression prior to differentiating into DP cells. CD25+ DP thymocytes have been observed21, 22, but only in settings in which pre-TCR signals are circumvented.

Figure 2. Identification of the signaling complex responsible for the generation of TCRbeta- DP cells in TCRalpha-transgenic mice.
Figure 2 thumbnail

(a) Thymocytes from TCRalpha transgene−negative (left column) and TCRalpha transgene−positive (middle column) mice were stained for CD4 and CD8 and analyzed by flow cytometry. Mean plusminus s.e.m. of total thymocytes (n = at least three mice for each group) are indicated below each contour plot; numbers above the contour plots indicate the percentages of DP thymocytes. (Right column) Mean plusminus s.e.m. absolute numbers of DP thymocytes generated in the absence (Tg -) or presence (Tg +) of the transgenic TCRalpha. (b) Signals from TCRalphagamma complexes result in the generation of CD25+ DP thymocytes. CD25 expression on DP thymocytes present in TCRbeta-/-delta-/- TCRalpha- transgenic (solid line) and normal B6 (dotted line) mice. Negative control staining is shown as a shaded area. (c) TCRalphagamma complexes signal CD25+ DN thymocytes to bypass the DN4 stage. Mean plusminus s.e.m absolute number of lineage-negative cells in various DN subpopulations from B6 (open bars) and TCRbeta-/-delta-/- TCRalpha-transgenic (filled bars) mice. (d) DP thymocytes in pTalpha-/- TCRalpha-transgenic mice are mostly TCRbeta-. DP thymocytes from the pTalpha-/- TCRalpha transgenic-mice in a were stained for intracellular TCRbeta (solid line) and compared to DP thymocytes from TCRbeta-/- (dotted line) and B6 (dashed line) mice.



Full FigureFull Figure and legend (68K)
Consistent with this perspective, DN4 (CD25-CD44-) thymocytes were markedly under-represented in TCRalpha-transgenic TCRbeta-/-delta-/- compared to DN thymocyte populations from normal B6 mice (Fig. 2c). Thus, TCRalpha expression in DN thymocytes appeared to result in formation of TCRalphagamma complexes that signaled CD25+ DN thymocytes to differentiate into TCRbeta- DP cells.

To further characterize the signaling complex that induced the DN to DP transition in TCRalpha-transgenic mice, we introduced the TCRalpha transgene into pTalpha-/-, TCRbeta-/- and CD3alt epsilon-/- mice (Fig. 2a, groups 3−5)14, 23, 24. In the absence of the TCRalpha transgene, pTalpha-/- and TCRbeta-/- thymi both contained approx1 times 106 DP thymocytes that resulted from TCRgammadelta signaling23, 25. In contrast, introduction of the TCRalpha transgene resulted in markedly greater numbers of DP thymocytes in both pTalpha-/- and TCRbeta-/- mice (Fig. 2a, groups 3, 4). Note that most of the DP thymocytes generated in TCRalpha-transgenic pTalpha-/- mice were TCRbeta- and so had been generated by putative TCRalphagamma complexes (Fig. 2d). Thus, signaling by putative TCRalphagamma complexes proceeded independently of both pTalpha and TCRbeta chains. On the other hand, CD3alt epsilon-/- mice were devoid of DP thymocytes, regardless of the presence or absence of the TCRalpha transgene (Fig. 2a, group 5). This indicated that TCRalphagamma complexes resemble all other TCR complexes in their requirement for CD3alt epsilon chains to transduce intracellular signals24, 26.

TCRalphabold gamma complexes consist of TCRalpha and TCR Cbold gamma4 chains
To characterize TCRalphagamma complexes biochemically, thymocyte lysates were immunoprecipitated with TCR antibodies, run on reducing SDS−polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotted with a TCRalpha-specific antibody that detects all TCRalpha proteins. If TCRalphagamma complexes exist in TCRalpha-transgenic thymocytes, transgenic TCRalpha proteins should be coprecipitated by TCRgamma antibodies. We found that transgenic TCRalpha proteins were not only immunoprecipitated by the TCRalpha clonotypic antibody A2B4 (Fig. 3a, lane 3), but they were also coprecipitated from thymocyte lysates by anti-TCRgamma specific for the TCR Cgamma4 chain (referred to hereafter as Cgamma4) (Fig. 3a, lane 1). Transgenic TCRalpha proteins were not coprecipitated by TCRgamma antibody that binds all other TCRgamma molecules, Cgamma1 Cgamma2 and Cgamma3 (Cgamma123) (Fig. 3a, lane 2), nor were they coprecipitated by TCRdelta antibody (Fig. 3a, lane 4). Thus, TCRalphagamma complexes consisted of TCRalpha and Cgamma4 chains.

Figure 3. Biochemical characterization of TCRalphabold gamma complexes.
Figure 3 thumbnail

(a) TCRalpha associates specifically with Cgamma4 chains. Digitonin lysates of thymocytes from TCRbeta-/- TCRalpha-transgenic mice were immunoprecipitated (IP) with the indicated antibodies and immunoblotted with anti-TCRalpha (mAb H28), which detects all TCRalpha proteins. Transgenic TCRalpha proteins were present in anti-Cgamma4 immunoprecipitates (lane 1), as well as in clonotypic A2B4 anti-TCRalpha immunoprecipitates (lane 3). N.S., nonspecific. (b) TCRalphagamma complexes form only in TCRalpha-transgenic thymocytes. Digitonin lysates of thymocytes from TCRbeta-/- mice with or without the TCRalpha transgene were immunoprecipitated with the indicated antibodies and immunoblotted with anti-TCRalpha. Asterick (*) indicates TCRalpha protein was present in anti-Cgamma4 immunoprecipitates. Cgamma4 immunoprecipitates were also blotted with anti-Cgamma4 (lanes 7, 8). (c) Most TCRalphagamma complexes are not transported beyond the medial Golgi. Digitonin lysates of thymocytes from B6 or TCRbeta-/- TCRalpha-transgenic mice were immunoprecipitated with antibodies to CD3alt epsilon (2c11), Cgamma4 or transgenic TCRalpha (A2B4). Immunoprecipitates were digested in the presence (+) or absence (-) of EndoH for 1 h at 37 °C. The presence of TCRalpha in these complexes was revealed by anti-TCRalpha immunoblotting. TCRalpha molecules in TCRalphabeta complexes from B6 lysates were mostly EndoH-resistant (TCRalphaR), with a minor pre-Golgi population that was EndoH-sensitive (TCRalphaS) (lanes 1, 2). In contrast, TCRalpha molecules in TCRalphagamma complexes from TCRbeta-/- TCRalpha-transgenic mice were almost entirely TCRalphaS (lanes 7, 8).



Full FigureFull Figure and legend (63K)
Next, we compared thymocyte lysates from TCRalpha-transgenic and nontransgenic mice, as TCRalphagamma complexes should only be formed in TCRalpha-transgenic thymocytes. In nontransgenic mice, TCRalpha and TCRgamma proteins are not expressed in the same cell. We found that Cgamma4 antibody only coprecipitated TCRalpha proteins from transgenic thymocyte lysates (Fig. 3b, lanes 5, 6; Fig. 3c, lanes 3, 7), even though the antibody precipitated Cgamma4 molecules from both transgenic and nontransgenic thymocyte lysates (Fig. 3b, lanes 7, 8). TCRalphagamma complexes were almost exclusively endoglycosidase H (EndoH)-sensitive (Fig. 3c, lanes 7, 8), indicating that too few TCRalphagamma complexes were transported beyond the medial Golgi to be detectable by protein immunoblotting. In contrast, conventional TCRalphabeta complexes in nontransgenic B6 thymocytes had both EndoH-sensitive and -resistant components (Fig. 3c, lanes 1, 2), with the resistant components mainly due to surface TCRalphabeta complexes. Thus, TCRalphagamma complexes are present in thymocyte lysates from TCRalpha-transgenic mice, are composed of transgenic TCRalpha proteins associated with endogenous Cgamma4 chains and do not appear in detectable quantities on the cell surface (a characteristic reminiscent of pre-TCR complexes).

Genetic reconstruction of TCRalphabold gamma complexes
To verify that the TCRalphagamma complexes we detected biochemically were actually responsible for signaling the generation of TCRbeta- DP thymocytes, we genetically reconstructed these complexes in DN thymocytes by introducing both TCRalpha and TCRgamma transgenes into RAG-/- mice (Fig. 4). The TCRgamma transgenes we used (encoding either Cgamma1 or Cgamma4) were both driven by endogenous TCRgamma control elements so that expression of these TCRgamma transgenes paralleled expression of endogenous TCRgamma molecules during intrathymic development27, 28. Confirming published data7, introduction of TCRgamma transgenes into RAG-/- mice resulted in the generation of small numbers (1 times 106−2 times 106) of DP thymocytes as a consequence of signals derived from pTalpha-TCRgamma complexes (Fig. 4). Introduction of the 2B4 TCRalpha transgene into these TCRgamma-transgenic RAG-/- mice created the genetic potential for formation of either TCRalpha-Cgamma4 signaling complexes (which we had detected biochemically) or TCRalpha-Cgamma1 signaling complexes (which we had not detected biochemically). Concordant with our biochemical analyses, we found that coexpression of TCRalpha and Cgamma4 chains in RAG-/- mice signaled the generation of over 57 times 106 DP thymocytes, whereas coexpression of the TCRalpha and Cgamma1 chains did not signal the generation of any DP thymocytes in RAG-/- mice (Fig. 4).

Figure 4. In vivo reconstruction of a TCRalphabold gamma complex in RAG-/- mice that signals the generation of DP thymocytes.
Figure 4 thumbnail

Thymocytes from RAG-/- mice were complemented with (left panels) each of two different TCRgamma transgenes or (middle panels) both TCRgamma and TCRalpha transgenes. (Right panels) The numbers of DP thymocytes that were generated in the absence (-TCRalpha Tg) or presence (+TCRalpha Tg) of the transgenic TCRalpha are indicated. DP thymocytes were only generated in RAG-/- mice that expressed both Cgamma4 and TCRalpha transgenes.



Full FigureFull Figure and legend (34K)
These results demonstrate that TCRalphagamma complexes that consist of TCRalpha and Cgamma4 chains form when expressed in the same DN cell and that they are highly efficient in signaling the generation of DP thymocytes. Note that TCRalpha Cgamma4-transgenic RAG-/- mice contained large numbers of DP thymocytes, but were devoid of single-positive (SP) T cells (Fig. 4). Because TCRgamma expression is silenced in DP thymocytes5, 6, 7, these DP thymocytes did not express TCR complexes on their surface (data not shown); thus, they are dead-end cells that cannot be positively selected for further maturation into SP T cells.

Effect of TCRalphabold gamma complexes on bold gammadeltaT cell generation
Having documented that formation of TCRalphagamma complexes in early DN thymocytes circumvents TCRbeta selection and impairs subsequent TCRalphabeta development, we next determined whether TCRalphagamma complex formation also affected gammadelta T cell development. Because TCRalphagamma complexes are only formed with Cgamma4 chains, TCRalphagamma complexes would only affect development of TCRgammadelta thymocytes that use Cgamma4 chains. Unfortunately, monoclonal antibodies (mAbs) that specifically stain Cgamma4 do not yet exist, but TCRgammadelta thymocytes expressing Cgamma4 chains can be identified by staining with Vgamma1.1 mAb, as Vgamma1 rearranges only with Cgamma4 and is expressed only on Cgamma4+ cells29, 30. Examination of DN TCRgammadelta+ thymocytes from TCRbeta-/- mice showed that overall numbers of TCRgammadelta+ thymocytes were somewhat reduced by the addition of the TCRalpha transgene (Fig. 5), but the reduction equally affected Vgamma1+ (that is, Cgamma4+) and Vgamma1- TCRgammadelta thymocytes and so was unlikely to result from TCRalphagamma complex formation (Fig. 5). We conclude that, unlike alphabeta T cell development, gammadelta T cell generation was not impaired by formation of TCRalphagamma complexes in TCRalpha-transgenic mice.

Figure 5. Expression of TCRalphabold gamma complexes in developing DN thymocytes does not impair TCRbold gammadelta development.
Figure 5 thumbnail

The potential effect of TCRalphagamma complex formation on gammadelta T cell differentiation was assessed by quantifying the number of DN TCRgammadelta+ thymocytes generated in TCRbeta-/- mice that either were or weren't transgenic for TCRalpha. Because TCRalphagamma complexes consist of TCRalpha and Cgamma4 chains, impairment of TCRgammadelta development by TCRalphagamma complex formation should have specifically reduced the number of TCRgammadelta+ thymocytes that were Vgamma1+, as Vgamma1 only rearranges with Cgamma4. Mean plusminus s.e.m absolute numbers of Vgamma1+ and Vgamma1- DN TCRgammadelta+ thymocytes in TCRbeta-/- littermate mice that either lacked (open bars) or expressed (filled bars) the transgenic TCRalpha are shown (n = seven mice per group). Although overall numbers of TCRgammadelta+ thymocytes were reduced in TCRbeta-/- TCRalpha-transgenic mice, the reduction was not specific for Vgamma1+ (that is, Cgamma4+) thymocytes, as it equally affected Vgamma1- thymocytes and so could not be attributed to TCRalphagamma complex formation.



Full FigureFull Figure and legend (11K)
 Top
Discussion
We have shown here that early TCRalpha expression results in the formation of isotype-mixed TCRalphagamma complexes that consist of TCRalpha chains paired to Cgamma4 chains. These TCRalphagamma complexes efficiently signal the DN to DP transition independently of the pTalpha, TCRbeta and TCRdelta chains. DN thymocytes are signaled by TCRalphagamma complexes at the CD25+ (that is, DN2 or DN3) stage of development to undergo a proliferative burst and to differentiate into DP cells. In this way, they circumvent the DN4 stage during which TCRbeta selection occurs and CD25 expression is down-regulated. As a result, TCRalphagamma signaled DN thymocytes differentiate into TCRbeta- DP cells that still express CD25. Because TCRgamma transcription is silenced at the DP stage of development5, 6, 7, such TCRbeta- DP thymocytes do not express any surface TCR complexes; thus, they are dead-end cells that cannot undergo further maturation.

TCRalphagamma exclusion is a feature of T cell development in normal animals, but it is abrogated in TCR-transgenic animals that prematurely express TCRalpha in early DN thymocytes. An unexpected consequence of coexpressing TCRalpha and TCRgamma proteins in the same DN thymocyte is their pairing and assembly into isotypically mixed TCRalphagamma complexes that are biologically functional in vivo. Although not previously described, the formation of TCRalphagamma complexes is concordant with the known principles for TCR assembly17, 18, 19. Assembly of TCR components into receptor complexes is largely regulated by transmembrane charges, so that clonotypic TCR chains with one transmembrane-positive charge only associate with clonotypic TCR chains with two transmembrane-positive charges. TCRalphagamma complexes conform to this basic paradigm. However, the TCRalphagamma complexes we detected here were limited to Cgamma4 chains, even though, in theory, other TCRgamma chains should also have been able to associate with TCRalpha. Because Vgamma domains are constrained to specific Cgamma domains29, 30, 31, it is conceivable that TCRalphagamma assembly may be limited by either C-region constraints or V-region incompatibilities that remain to be identified.

TCRalphagamma is not unique in its ability to signal the DN to DP transition by circumventing TCRbeta selection, as TCRgammadelta and pTalpha-TCRgamma complexes also share this property5, 6, 7. However, TCRgammadelta and pTalpha-TCRgamma signals do not induce DN thymocytes to undergo a proliferative burst and so they generate few TCRbeta- DP thymocytes. In contrast, the large numbers of TCRbeta- DP thymocytes generated by TCRalphagamma signals indicate that TCRalphagamma signals do induce DN thymocytes to undergo a proliferative burst, which appears to be as extensive as that signaled by the pre-TCR. As a result, aberrant TCRgammadelta and pTalpha-TCRgamma signals can be tolerated during normal alphabeta T cell differentiation, but TCRalphagamma signaling must be avoided.

Although TCRalphagamma complexes markedly altered alphabeta T cell differentiation, TCRalphagamma complexes did not appear to affect TCRgammadelta development, as TCRVgamma1+ thymocytes were not specifically depleted from the TCRgammadelta pool. We assessed the representation of Vgamma1+ thymocytes among TCRdelta+ cells as a measure of the frequency of Cgamma4+ thymocytes in the TCRgammadelta pool, as reagents do not yet exist to directly examine C